The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
Bile Acids and Their Derivatives as Potential Modifiers of Drug Release and Pharmacokinetic Profiles
Open accessAbstract
Bile acids have received considerable interest in the drug delivery research due to their peculiar physicochemical properties and biocompatibility. The main advantage of bile acids as drug absorption enhancers is their ability to act as both drug solubilizing and permeation-modifying agents. Therefore, bile acids may improve bioavailability of drugs whose absorption-limiting factors include either poor aqueous solubility or low membrane permeability. Besides, bile acids may withstand the gastrointestinal impediments and aid in the transporter-mediated absorption of physically complexed or chemically conjugated drug molecules. These biomolecules may increase the drug bioavailability also at submicellar levels by increasing the solubility and dissolution rate of non-polar drugs or through the partition into the membrane and increase of membrane fluidity and permeability. Most bile acid-induced effects are mediated by the nuclear receptors that activate transcriptional networks, which then affect the expression of a number of target genes, including those for membrane transport proteins, affecting the bioavailability of a number of drugs. Besides micellar solubilization, there are many other types of interactions between bile acids and drug molecules, which can influence the drug transport across the biological membranes. Most common drug-bile salt interaction is ion-pairing and the formed complexes may have either higher or lower polarity compared to the drug molecule itself. Furthermore, the hydroxyl and carboxyl groups of bile acids can be utilized for the covalent conjugation of drugs, which changes their physicochemical and pharmacokinetic properties. Bile acids can be utilized in the formulation of conventional dosage forms, but also of novel micellar, vesicular and polymer-based therapeutic systems. The availability of bile acids, along with their simple derivatization procedures, turn them into attractive building blocks for the design of novel pharmaceutical formulations and systems for the delivery of drugs, biomolecules and vaccines. Although toxic properties of hydrophobic bile acids have been described, their side effects are mostly produced when present in supraphysiological concentrations. Besides, minor structural modifications of natural bile acids may lead to the creation of bile acid derivatives with the reduced toxicity and preserved absorption-enhancing activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bile salt biotransformations by human intestinal bacteria
Ridlon, J. M., Kang, D.-J., & Hylemon, P. B. (2006) · Journal of Lipid Research · doi:10.1194/jlr.r500013-jlr200 · Cited by 2,829
Transport properties of two finite armchair graphene nanoribbons
Rosales, L., & González, J. W. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-1 · Cited by 1,956
Williams, A. C., & Barry, B. W. (2004) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2003.10.025 · Cited by 1,746
Consequences of bile salt biotransformations by intestinal bacteria
Ridlon, J. M., Harris, S. C., Bhowmik, S., Kang, D.-J., & Hylemon, P. B. (2016) · Gut Microbes · doi:10.1080/19490976.2015.1127483 · Cited by 1,100
Bile Acids: Chemistry, Pathochemistry, Biology, Pathobiology, and Therapeutics
Hofmann, A. F., & Hagey, L. R. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-7568-6 · Cited by 859
Bile-acid-induced cell injury and protection
Perez, M. J., & Briz, O. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1677 · Cited by 717
Transdermal Drug Delivery: Penetration Enhancement Techniques
Benson, H. (2005) · Current Drug Delivery · doi:10.2174/1567201052772915 · Cited by 712
The role of bile salts in digestion
Maldonado-Valderrama, J., Wilde, P., Macierzanka, A., & Mackie, A. (2011) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2010.12.002 · Cited by 572
Bile acids: Chemistry, physiology, and pathophysiology
Monte, M. J., Marin, J. J., Antelo, A., & Vazquez-Tato, J. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.804 · Cited by 569
Critical factors in the release of drugs from sustained release hydrophilic matrices
Maderuelo, C., Zarzuelo, A., & Lanao, J. M. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.04.002 · Cited by 551
Li, J., Huo, M., Wang, J., Zhou, J., Mohammad, J. M., Zhang, Y., Zhu, Q., Waddad, A. Y., & Zhang, Q. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2011.11.022 · Cited by 468
Lipophilicity and Its Relationship with Passive Drug Permeation
Liu, X., Testa, B., & Fahr, A. (2011) · Pharmaceutical Research · doi:10.1007/s11095-010-0303-7 · Cited by 459
Penetration and enzymatic barriers to peptide and protein absorption
Lee, V. H. L., & Yamamoto, A. (1989) · Advanced Drug Delivery Reviews · doi:10.1016/0169-409x(89)90018-5 · Cited by 413
Gupta, S., Kesarla, R., & Omri, A. (2013) · ISRN Pharmaceutics · doi:10.1155/2013/848043 · Cited by 380
Bile acids: regulation of apoptosis by ursodeoxycholic acid
Amaral, J. D., Viana, R. J. S., Ramalho, R. M., Steer, C. J., & Rodrigues, C. M. P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.r900011-jlr200 · Cited by 363
Carcinogenicity of deoxycholate, a secondary bile acid
Bernstein, C., Holubec, H., Bhattacharyya, A. K., Nguyen, H., Payne, C. M., Zaitlin, B., & Bernstein, H. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0648-7 · Cited by 351
Nasal absorption of insulin: enhancement by hydrophobic bile salts.
Gordon, G. S., Moses, A. C., Silver, R. D., Flier, J. S., & Carey, M. C. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.21.7419 · Cited by 278
Chen, Y., Lu, Y., Chen, J., Lai, J., Sun, J., Hu, F., & Wu, W. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.022 · Cited by 274
Dima, C., Pătraşcu, L., Cantaragiu, A., Alexe, P., & Dima, Ş. (2016) · Food Chemistry · doi:10.1016/j.foodchem.2015.05.044 · Cited by 270
Absorption-Enhancing Effects of Bile Salts
Moghimipour, E., Ameri, A., & Handali, S. (2015) · Molecules · doi:10.3390/molecules200814451 · Cited by 255
Microencapsulation of protein drugs for drug delivery: Strategy, preparation, and applications
Ma, G. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.09.003 · Cited by 250
Niu, M., Lu, Y., Hovgaard, L., Guan, P., Tan, Y., Lian, R., Qi, J., & Wu, W. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.02.009 · Cited by 248
A self-assembling nanoparticle for paclitaxel delivery in ovarian cancer
Xiao, K., Luo, J., Fowler, W. L., Li, Y., Lee, J. S., Xing, L., Cheng, R. H., Wang, L., & Lam, K. S. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.07.015 · Cited by 238
Al-mahallawi, A. M., Abdelbary, A. A., & Aburahma, M. H. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.03.033 · Cited by 237
The safety of pharmaceutical excipients
Pifferi, G., & Restani, P. (2003) · Il Farmaco · doi:10.1016/s0014-827x(03)00079-x · Cited by 226
Bile salts and their importance for drug absorption
Holm, R., Müllertz, A., & Mu, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.04.003 · Cited by 217
Roda, A., Minutello, A., Angellotti, M., & Fini, A. (1990) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42614-8 · Cited by 199
Abdelbary, A. A., Abd-Elsalam, W. H., & Al-mahallawi, A. M. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.10.006 · Cited by 188
Hu, S., Niu, M., Hu, F., Lu, Y., Qi, J., Yin, Z., & Wu, W. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2012.10.025 · Cited by 180
Bile Acids in Physiology, Pathology and Pharmacology
J.G. Marin, J., I.R. Macias, R., Briz, O., M. Banales, J., & J. Monte, M. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666151103115454 · Cited by 179
Qi, J., Dai, Zhou, Lu, Y., Wu, W., & Liu (2013) · International Journal of Nanomedicine · doi:10.2147/ijn.s44487 · Cited by 176
Interfacial Characterization of β-Lactoglobulin Networks: Displacement by Bile Salts
Maldonado-Valderrama, J., Woodward, N. C., Gunning, A. P., Ridout, M. J., Husband, F. A., Mackie, A. R., Morris, V. J., & Wilde, P. J. (2008) · Langmuir · doi:10.1021/la800551u · Cited by 175
Solubility and dissolution enhancement strategies: current understanding and recent trends
Jain, S., Patel, N., & Lin, S. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2014.971027 · Cited by 169
Intestinal bile acid physiology and pathophysiology
Martínez-Augustin, O., & Medina, F. S. D. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5630 · Cited by 162
Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt
Wu, W., Guan, P., & Wu, W. (2011) · International Journal of Nanomedicine · doi:10.2147/ijn.s19259 · Cited by 160
Bile acids and bile acid derivatives: use in drug delivery systems and as therapeutic agents
Faustino, C. M. C., Serafim, C., Rijo, P. M., & Reis, C. P. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1178233 · Cited by 155
Application of bile acids in drug formulation and delivery
Đanić, M., Pavlović, N., Goločorbin-Kon, S., & Mikov, M. (2013) · Frontiers in Life Science · doi:10.1080/21553769.2013.879925 · Cited by 154
Self-citationFunctions of Lipids for Enhancement of Oral Bioavailability of Poorly Water-Soluble Drugs
Nanjwade, B. K., Patel, D. J., Udhani, R. A., & Manvi, F. V. (2011) · Scientia Pharmaceutica · doi:10.3797/scipharm.1105-09 · Cited by 146
Strategies to improve oral drug bioavailability
Gómez-Orellana, I. (2005) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2.3.419 · Cited by 144
Enhanced intestinal absorption of salmon calcitonin (sCT) from proliposomes containing bile salts
Song, K., Chung, S., & Shim, C. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.05.016 · Cited by 140
Polymeric Materials Containing Bile Acids
Zhu, X.-X., & Nichifor, M. (2002) · Accounts of Chemical Research · doi:10.1021/ar0101180 · Cited by 139
Liver-specific drug targeting by coupling to bile acids.
Kramer, W., Wess, G., Schubert, G., Bickel, M., Girbig, F., Gutjahr, U., Kowalewski, S., Baringhaus, K. H., Enhsen, A., & Glombik, H. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)37003-6 · Cited by 133
Preparation methods and applications behind alginate-based particles
Lopes, M., Abrahim-Vieira, B. D. A., Veiga, F., Seiça, R. M. F., Cabral, L. M., Arnaud, P., Andrade, J. C., & Ribeiro, A. J. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1214564 · Cited by 131
Saettone, M. F., Chetoni, P., Cerbai, R., Mazzanti, G., & Braghiroli, L. (1996) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(96)04663-7 · Cited by 129
Dadashzadeh, S., Haeri, A., Daeihamed, M., Arzani, G., & Kaboutaraki, H. B. (2015) · International Journal of Nanomedicine · doi:10.2147/ijn.s84703 · Cited by 126
Increased Acyclovir Oral Bioavailability via a Bile Acid Conjugate
Tolle‐Sander, S., Lentz, K. A., Maeda, D. Y., Coop, A., & Polli, J. E. (2003) · Molecular Pharmaceutics · doi:10.1021/mp034010t · Cited by 120
An examination of the factors affecting intestinal lymphatic transport of dietary lipids
Nordskog, B. K. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00147-8 · Cited by 116
A review of polymers as multifunctional excipients in drug dosage form technology
Karolewicz, B. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.02.025 · Cited by 115
Amjad, M. W., Amin, M. C. I. M., Katas, H., Butt, A. M., Kesharwani, P., & Iyer, A. K. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00827 · Cited by 112
Bile Acids Modulate Signaling by Functional Perturbation of Plasma Membrane Domains
Zhou, Y., Maxwell, K. N., Sezgin, E., Lu, M., Hong, L., Hancock, J. F., Dial, E. J., Lichtenberger, L. M., & Levental, I. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.519116 · Cited by 104
Bile Acids Improve the Antimicrobial Effect of Rifaximin
Darkoh, C., Lichtenberger, L. M., Ajami, N. J., Dial, E. J., Jiang, Z., & DuPont, H. L. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00161-10 · Cited by 104
Payen, L. F., Delugin, L., Courtois, A., Trinquart, Y., Guillouzo, A., & Fardel, O. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703863 · Cited by 97
Microbiome-mediated bile acid modification: Role in intestinal drug absorption and metabolism
Enright, E. F., Griffin, B. T., Gahan, C. G. M., & Joyce, S. A. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.04.009 · Cited by 92
Pharmacology of bile acids and their derivatives: Absorption promoters and therapeutic agents
Mikov, M., Fawcett, J. P., Kuhajda, K., & Kevrešan, S. (2006) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03190714 · Cited by 89
Self-citationNuclear-receptor–mediated regulation of drug– and bile-acid–transporter proteins in gut and liver
Staudinger, J. L., Woody, S. K., Sun, M., & Cui, W. (2013) · Drug Metabolism Reviews · doi:10.3109/03602532.2012.748793 · Cited by 88
Barrios, J. M., & Lichtenberger, L. M. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70371-4 · Cited by 88
The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs
Stojančević, M., Bojić, G., Salami, H. A., & Momir, M. (2014) · Current Issues in Molecular Biology · doi:10.21775/cimb.016.055 · Cited by 86
Synthesis and Biological Properties of Insulin−Deoxycholic Acid Chemical Conjugates
Lee, S., Kim, K., Kumar, T. S., Lee, J. S., Kim, S. K., Lee, D. Y., Lee, Y.-K., & Byun, Y. (2005) · Bioconjugate Chemistry · doi:10.1021/bc049871e · Cited by 85
Enright, E. F., Joyce, S. A., Gahan, C. G. M., & Griffin, B. T. (2017) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b01155 · Cited by 81
Intestinal absorption of peptides by coupling to bile acids.
Kramer, W., Wess, G., Neckermann, G., Schubert, G., Fink, J., Girbig, F., Gutjahr, U., Kowalewski, S., Baringhaus, K. H., & Boeger, G. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34105-4 · Cited by 80
Meaney, C., & O’Driscoll, C. M. (2000) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(00)00526-3 · Cited by 77
The effect of food and bile acid administration on the relative bioavailability of cyclosporin.
Lindholm, A., Henricsson, S., & Dahlqvist, R. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb03677.x · Cited by 76
Solubilization of resveratrol in micellar solutions of different bile acids
Krstonošić, M. A., Poša, M., Heinle, H., et al. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.03.029 · Cited by 72
Matsuoka, K., Suzuki, M., Honda, C., Endo, K., & Moroi, Y. (2005) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2005.08.006 · Cited by 72
The Influence of Intestinal Tract and Probiotics on the Fate of Orally Administered Drugs.
Stojančević, M., Bojić, G., Al‐Salami, H., & Mikov, M. (2014) · PubMed · Cited by 66
Self-citationAl‐Salami, H., Butt, G., Tucker, I. G., & Mikov, M. (2008) · Methods and Findings in Experimental and Clinical Pharmacology · doi:10.1358/mf.2008.30.2.1159652 · Cited by 66
Self-citationTournier, N., Saba, W., Cisternino, S., Peyronneau, M., Damont, A., Goutal, S., Dubois, A., Dollé, F., Scherrmann, J., Valette, H., et al. (2013) · The AAPS Journal · doi:10.1208/s12248-013-9514-2 · Cited by 64
Kramer, W. (2011) · Biological Chemistry · doi:10.1515/bc.2011.017 · Cited by 64
Design and strategies for bile acid mediated therapy and imaging
Nurunnabi, M., Khatun, Z., Revuri, V., Nafiujjaman, M., Cha, S., Cho, S., Huh, K. M., & Lee, Y.-K. (2016) · RSC Advances · doi:10.1039/c6ra10978k · Cited by 64
Poelma, F. G. J., Breäs, R., & Tukker, J. J. (1990) · Pharmaceutical Research · doi:10.1023/a:1015827624296 · Cited by 62
Lalic-Popovic, M. N., Vasović, V., Milijašević, B., Goločorbin-Kon, S., Al‐Salami, H., & Mikov, M. (2013) · Journal of Diabetes Research · doi:10.1155/2013/598603 · Cited by 60
Self-citationTang, X., Cai, S., Zhang, R., Liu, P., Chen, H., Zheng, Y., & Sun, L. (2013) · Nanoscale Research Letters · doi:10.1186/1556-276x-8-420 · Cited by 60
Oligomeric bile acid-mediated oral delivery of low molecular weight heparin
Al-Hilal, T. A., Park, J., Alam, F., Chung, S. W., Park, J. W., Kim, K., Kwon, I. C., Kim, I.-S., Kim, S. Y., & Byun, Y. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.12.001 · Cited by 57
Bile acid signaling through farnesoid X and TGR5 receptors in hepatobiliary and intestinal diseases
Stanimirov, B., Stankov, K., & Mikov, M. (2015) · Hepatobiliary & pancreatic diseases international · doi:10.1016/s1499-3872(14)60307-6 · Cited by 57
Self-citationArafat, M., Kirchhoefer, C., Mikov, M., Sarfraz, M., & Löbenberg, R. (2017) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j3ck88 · Cited by 56
Self-citationA mechanistic study on enhancement of rectal permeability to insulin in the albino rabbit.
Yamamoto, A., Hayakawa, E., Kato, Y., Nishiura, A., & Lee, V. H. L. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10333-9 · Cited by 55
Al‐Salami, H., Mooranian, A., Negrulj, R., Chen‐Tan, N., Watts, G. F., & Arfuso, F. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s68247 · Cited by 53
Self-citationAl‐Salami, H., Mooranian, A., Negrulj, R., Chen‐Tan, N., Al-Sallami, H. S., Fang, Z., Mukkur, T. K. S., Mikov, M., Goločorbin-Kon, S., Arfuso, F., et al. (2014) · Drug Design Development and Therapy · doi:10.2147/dddt.s65396 · Cited by 53
Self-citationInhibit multidrug resistance and induce apoptosis by using glycocholic acid and epirubicin
Lo, Y., Ho, C., & Tsai, F. L. (2008) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2008.06.003 · Cited by 52
Alam, F., Al-Hilal, T. A., Chung, S. W., Seo, D.-H., Mahmud, F., Kim, H. S., Kim, S. Y., & Byun, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.050 · Cited by 51
Digestion and absorption of lipids
Lairon, D. (2009) · Elsevier eBooks · doi:10.1533/9781845696603.1.66 · Cited by 50
Lecithin in mixed micelles attenuates the cytotoxicity of bile salts in Caco-2 cells
Tan, Y., Qi, J., Lü, Y., Hu, F., Yin, Z., & Wu, W. (2012) · Toxicology in Vitro · doi:10.1016/j.tiv.2012.11.018 · Cited by 50
Mooranian, A., Negrulj, R., Mikov, M., Goločorbin-Kon, S., Arfuso, F., & Al‐Salami, H. (2015) · Journal of Microencapsulation · doi:10.3109/02652048.2015.1065922 · Cited by 46
Self-citationMikov, M., Al‐Salami, H., Goločorbin-Kon, S., Škrbić, R., Rašković, A., & Fawcett, J. P. (2008) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03191110 · Cited by 46
Self-citationO'Reilly, J. R., Corrigan, O. I., & O’Driscoll, C. M. (1994) · International Journal of Pharmaceutics · doi:10.1016/0378-5173(94)90142-2 · Cited by 45
Lozano, E., Monte, M. J., Briz, Ó., Hernández‐Hernández, Á., Bañales, J. M., Marı́n, J. J. G., & Macı́as, R. I. R. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.022 · Cited by 43
Miyake, M., Minami, T., Hirota, M., Toguchi, H., Odomi, M., Ogawara, K., Higaki, K., & Kimura, T. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.11.010 · Cited by 43
3Alpha,7alpha-dihydroxy-12-oxo-5beta-cholanate as blood-brain barrier permeator.
Mikov, M., Kevrešan, S., Kuhajda, K., Jakovljević, V., & Vasović, V. (2004) · PubMed · Cited by 42
Self-citationSingh, M. P., Singh, A., Kundu, S., Bansal, S., & Bajaj, A. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2013.04.003 · Cited by 41
In vitro and in vivo investigation of the gastrointestinal behavior of simvastatin
Geboers, S., Stappaerts, J., Tack, J. F., Annaert, P., & Augustijns, P. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.048 · Cited by 40
Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel
Zhang, X., Wu, Y., Zhang, M., Mao, J. Y., Wu, Y., Zhang, Y., Ju, Y., Xu, C., Guo, W., & Yu, B. (2017) · International Journal of Nanomedicine · doi:10.2147/ijn.s150196 · Cited by 40
Rais, R., Fletcher, S., & Polli, J. E. (2010) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22332 · Cited by 39
Transporter-targeted cholic acid-cytarabine conjugates for improved oral absorption
Zhang, D., Li, D., Shang, L., He, Z., & Sun, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.06.139 · Cited by 39
Mikov, M., Đanić, M., Pavlović, N., Stanimirov, B., Goločorbin-Kon, S., Stankov, K., & Al‐Salami, H. (2017) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/s13318-017-0441-y · Cited by 36
Self-citationPleiotropic functions of bile acids mediated by the farnesoid X receptor.
Stanimirov, B., Stankov, K., & Mikov, M. (2012) · PubMed · Cited by 32
Self-citationMahmud, F., Jeon, O., Al-Hilal, T. A., Kweon, S., Yang, V. C.-M., Lee, D. S., & Byun, Y. (2015) · Molecular Pharmaceutics · doi:10.1021/mp500626a · Cited by 29
Intranasal Melatonin Nanoniosomes: Pharmacokinetic, Pharmacodynamics and Toxicity Studies
Priprem, A., Johns, J. R., Limsitthichaikoon, S., Limphirat, W., Mahakunakorn, P., & Johns, N. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0005 · Cited by 28
Kim, J. M., Kim, D., Ramasamy, T., Choi, J. Y., Kim, J. H., Yong, C. S., & Choi, H. (2014) · International Journal of Nanomedicine · doi:10.2147/ijn.s64794 · Cited by 27
Lipoamino acid-based micelles as promising delivery vehicles for monomeric amphotericin B
Serafim, C., Ferreira, I. R., Rijo, P. M., Pinheiro, L. M. V., Faustino, C. M. C., Calado, A. R. T., & García‐Río, L. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.11.034 · Cited by 26
Chen, G., Fawcett, J. P., Mikov, M., & Tucker, I. G. (2009) · Journal of Pharmacy and Pharmacology · doi:10.1211/jpp.61.07.0016 · Cited by 24
Self-citationWoodhams, L., & Al‐Salami, H. (2017) · Therapeutic Delivery · doi:10.4155/tde-2017-0010 · Cited by 24
Self-citationTønsberg, H., Holm, R., Mu, H., Boll, J. B., Jacobsen, J., & Müllertz, A. (2011) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.2011.01286.x · Cited by 22
Gaowa, A., Horibe, T., Kohno, M., & Kawakami, K. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.12.012 · Cited by 21
Dulfer, W. J., & Govers, H. A. J. (1995) · Chemosphere · doi:10.1016/0045-6535(94)00390-g · Cited by 20
Goločorbin-Kon, S., Mikov, M., Arafat, M., Lepojević, Ž., Mikov, I., Šahman-Zaimović, M., & Tomić, Z. (2009) · European Journal of Drug Metabolism and Pharmacokinetics · doi:10.1007/bf03191381 · Cited by 18
Self-citationEnhanced Oral Absorption of Ibandronate via Complex Formation with Bile Acid Derivative
Park, J. W., Hwang, S. R., Jeon, O., Moon, H. T., & Byun, Y. (2012) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23413 · Cited by 18
Sreekanth, V., Medatwal, N., Kumar, S., Pal, S., Malyla, V., Kar, A., Bhargava, P., Naaz, A., Kumar, N., Sengupta, S., et al. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00564 · Cited by 18
Effects of tauroursodeoxycholate solutions on cyclosporin A bioavailability in rats.
Balandraud, N., Queneau, P. E., Caroli‐Bosc, F., Bertault-Pérès, P., Montet, A. M., Durand, A., & Montet, J. C. (1997) · PubMed · Cited by 15
Giovagnoli, S., Pietrella, D., Barberini, L., Santi, C., Carotti, A., Michele, A. D., & Ricci, M. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.06.008 · Cited by 12
Cholic Acid-Based Novel Micellar Nanoplatform for Delivering FDA-Approved Taxanes
Bharadwaj, G., Nhan, V., Yang, S., Li, X., Narayanan, A., Macarenco, A. C., Shi, Y., Yang, D., Vieira, L. S., Xiao, W., et al. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0361 · Cited by 11
The absorption enhancer sodium deoxycholate promotes high gene transfer in skeletal muscles
Leborgne, C., Alimi‐Guez, D., Shafey, N. E., van Wittenberghe, L., Bigey, P., Scherman, D., & Kichler, A. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.020 · Cited by 6
Tan, Q., Bie, M., Wang, Z., Chu, Y., Tao, S., Xu, X., & Liu, Y. (2018) · ChemistrySelect · doi:10.1002/slct.201800382 · Cited by 6
Cited by
Vinarov, Z., Abdallah, M., Agundez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 359
Bile acids and their receptors in metabolic disorders
Fiorucci, S., Distrutti, E., Carino, A., Zampella, A., & Biagioli, M. (2021) · Progress in Lipid Research · doi:10.1016/j.plipres.2021.101094 · Cited by 258
Recharla, N., Geesala, R., & Shi, X.-Z. (2023) · Nutrients · doi:10.3390/nu15102275 · Cited by 256
A dysregulated bile acid-gut microbiota axis contributes to obesity susceptibility
Wei, M., Huang, F., Zhao, L., Zhang, Y., Yang, W., Wang, S., Li, M., Han, X., Ge, K., Qu, C., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102766 · Cited by 253
The influence of probiotics on bile acids in diseases and aging
Sivamaruthi, B. S., Fern, L. A., Rashidah Pg Hj Ismail, D. S. N., & Chaiyasut, C. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110310 · Cited by 73
Metadata
- Authors
- Pavlović, N., Goločorbin-Kon, S., Ðanić, M., Stanimirov, B., Al-Salami, H., Stankov, K., & Mikov, M.
- Venue
- Frontiers in Pharmacology
- Publisher
- Frontiers Media SA
- Published
- 2018-11-08
- Volume
- 9
- Pages
- 1283-1283
- ISSN
- 1663-9812 (ISSN-L)
- OpenAlex
- W2895934010
- Cited by
- 305
- References
- 112
- FWCI
- 8.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.